ECSP941082A - Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida - Google Patents

Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida

Info

Publication number
ECSP941082A
ECSP941082A EC1994001082A ECSP941082A ECSP941082A EC SP941082 A ECSP941082 A EC SP941082A EC 1994001082 A EC1994001082 A EC 1994001082A EC SP941082 A ECSP941082 A EC SP941082A EC SP941082 A ECSP941082 A EC SP941082A
Authority
EC
Ecuador
Prior art keywords
carboxamide
tenoli
adhidra
oxindol
sodic
Prior art date
Application number
EC1994001082A
Other languages
English (en)
Inventor
Douglas John Meldrum Allen
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP941082A publication Critical patent/ECSP941082A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Una sal sódica cristalina anhídrida de 5-cloro-3-(2-tenol)-2-oxindol-1- carboxamida que tiene valiosas propiedades para fórmulas como agente analgésico y antiinflamatorio.
EC1994001082A 1987-02-02 1994-05-05 Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida ECSP941082A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
ECSP941082A true ECSP941082A (es) 1994-12-15

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
EC1994001082A ECSP941082A (es) 1987-02-02 1994-05-05 Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida

Country Status (42)

Country Link
US (1) US5036099A (es)
EP (1) EP0277738B1 (es)
JP (1) JPS63201184A (es)
KR (1) KR900001422B1 (es)
CN (1) CN1022324C (es)
AP (1) AP52A (es)
AR (1) AR243182A1 (es)
AT (1) ATE73800T1 (es)
AU (1) AU587736B2 (es)
BG (1) BG51042A3 (es)
CA (1) CA1335590C (es)
CS (2) CS265250B2 (es)
CY (1) CY1775A (es)
DD (1) DD267490A5 (es)
DE (1) DE3869149D1 (es)
DK (1) DK44888A (es)
EC (1) ECSP941082A (es)
ES (1) ES2032955T3 (es)
FI (1) FI89598C (es)
GR (1) GR3004200T3 (es)
HK (1) HK132695A (es)
IE (1) IE60000B1 (es)
IL (1) IL85277A (es)
IN (1) IN171799B (es)
IS (1) IS1533B (es)
LV (1) LV10252B (es)
MA (1) MA21171A1 (es)
MY (1) MY102737A (es)
NO (1) NO170581C (es)
NZ (1) NZ223373A (es)
OA (1) OA08710A (es)
PH (1) PH26545A (es)
PL (1) PL149550B1 (es)
PT (1) PT86675B (es)
RO (1) RO105052B1 (es)
RU (1) RU2011381C1 (es)
SG (1) SG27994G (es)
SI (1) SI8810183A8 (es)
UA (1) UA25898A1 (es)
WO (1) WO1988005656A1 (es)
YU (1) YU46766B (es)
ZA (1) ZA88679B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
SK278175B6 (en) * 1988-10-18 1996-03-06 Pfizer 3-acyl-2-oxindole-1-carboxamides and method of their preparation
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) * 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
BR112020008852A2 (pt) 2017-11-02 2020-10-20 Accurate Medical Therapeutics Ltd. cateter para embolização com filtro integrado

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B (es) * 1984-03-19 1985-07-25 Pfizer
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
JPH0576945B2 (es) 1993-10-25
FI89598C (fi) 1993-10-25
IE880269L (en) 1988-08-02
OA08710A (fr) 1989-03-31
EP0277738B1 (en) 1992-03-18
CN88100555A (zh) 1988-08-17
LV10252A (lv) 1994-10-20
NO170581C (no) 1992-11-04
WO1988005656A1 (en) 1988-08-11
FI893647A0 (fi) 1989-08-01
IL85277A0 (en) 1988-07-31
CY1775A (en) 1996-04-05
PL149550B1 (en) 1990-02-28
NZ223373A (en) 1989-06-28
IS3309A7 (is) 1988-08-03
PH26545A (en) 1992-08-19
ES2032955T3 (es) 1996-07-16
PT86675A (pt) 1988-03-01
NO884329L (no) 1988-09-29
HK132695A (en) 1995-09-01
AP8800081A0 (en) 1987-11-01
CS64888A2 (en) 1988-08-16
MA21171A1 (fr) 1988-10-01
NO884329D0 (no) 1988-09-29
DE3869149D1 (de) 1992-04-23
MY102737A (en) 1992-09-30
SG27994G (en) 1994-10-14
AR243182A1 (es) 1993-07-30
IN171799B (es) 1993-01-09
FI89598B (fi) 1993-07-15
PT86675B (pt) 1992-07-31
KR900001422B1 (ko) 1990-03-09
NO170581B (no) 1992-07-27
BG51042A3 (en) 1993-01-15
US5036099A (en) 1991-07-30
IS1533B (is) 1994-01-28
UA25898A1 (uk) 1999-02-26
YU18388A (en) 1989-10-31
GR3004200T3 (es) 1993-03-31
KR880009961A (ko) 1988-10-06
YU46766B (sh) 1994-05-10
IE60000B1 (en) 1994-05-18
PL270415A1 (en) 1988-12-08
RU2011381C1 (ru) 1994-04-30
EP0277738A1 (en) 1988-08-10
AU1116088A (en) 1988-08-04
DK44888D0 (da) 1988-01-29
IL85277A (en) 1994-02-27
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
ZA88679B (en) 1989-09-27
CN1022324C (zh) 1993-10-06
SI8810183A8 (sl) 1996-08-31
RO105052B1 (en) 1994-12-01
DK44888A (da) 1988-08-03
CA1335590C (en) 1995-05-16
AU587736B2 (en) 1989-08-24
DD267490A5 (de) 1989-05-03
AP52A (en) 1989-09-16
CS354191A3 (en) 1992-04-15
CS265250B2 (en) 1989-10-13
ATE73800T1 (de) 1992-04-15

Similar Documents

Publication Publication Date Title
ECSP941082A (es) Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida
ES2196054T3 (es) Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos.
ES2068862T3 (es) Derivado de 3'-hidroxibenzoxazinorifamicina; procedimiento para la preparacion del mismo y agente antibacteriano que contiene el mismo.
EA200000711A1 (ru) 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
CU23006A3 (es) Nuevos ésteres derivados de compuestos fenil-ciclonuevos ésteres derivados de compuestos fenil-ciclohexil sustituidos hexil sustituidos
SE7910371L (sv) Oralt intagbart lekemedel med inflammationshemmande verkan
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
ES2058547T3 (es) Fuente organica de fluoruro.
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
ES2045180T3 (es) Nuevo procedimiento para la obtencion de 4-aciloxi-3-hidroxietil-azetidinonas.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
ES2058125T3 (es) Derivados de piperidina para el tratamiento del dolor.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
ES542317A0 (es) Procedimiento para la obtencion de antiflogisticos de depo- sito
ES2079349T3 (es) Sales por adicion de acidos de cefem cristalizadas y procedimiento para su preparacion.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
AR240018A1 (es) Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
PT81933B (pt) Processo para a preparacao de composicoes aperfeicoadas anti-inflamatorias contendo piroxicamo e inositol
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.